Seelos Therapeutics Inc SEEL

NAS: SEEL | ISIN: US81577F1093   15:42
0,300 USD (+7,53%)
(+7,53%)   15:42
Grafiek Seelos Therapeutics Inc Grafiek Seelos Therapeutics Inc

Seelos Therapeutics Inc in het nieuws

29 april 2024 · Seelos Therapeutics Announces Strategic Focus on Mental Health Initiatives and Provides an Update on Current Discussions of Potential Partnerships and Collaborations · Persbericht

19 maart 2024 · Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis (ALS) Study with SLS-005 (IV Trehalose) · Persbericht

26 januari 2024 · Seelos Therapeutics, Inc. Announces $4.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

22 januari 2024 · Seelos Therapeutics Announces Receipt of Minutes from its End of Phase II Meeting with the United States Food and Drug Administration (FDA) Highlighting Modifications to the Primary and Secondary Endpoints of its Phase II Study of SLS-002 · Persbericht

2 januari 2024 · Leading Independent Proxy Advisory Firm ISS Recommends Seelos Stockholders Vote "FOR" All Proxy Proposals at the Special Meeting to be held on January 10, 2024 · Persbericht

22 december 2023 · Seelos Therapeutics, Inc. Releases Letter to its Stockholders · Persbericht

1 december 2023 · Seelos Therapeutics Announces Closing of Public Offering · Persbericht

27 oktober 2023 · Seelos Therapeutics to Present a Poster on SLS-005 in Alzheimer's Disease at Neuroscience 2023 · Persbericht

17 oktober 2023 · Seelos Therapeutics Retains Canaccord Genuity in Connection with Review of Potential Partnerships and Collaborations · Persbericht

28 september 2023 · Thinking about buying stock in Oncolytics Biotech, Near Intelligence, Basin Uranium, Seelos Therapeutics, or MillerKnoll? · Persbericht

Profiel Seelos Therapeutics Inc

Biotechnologie
Fabricage van farmaceutische preparaten
Farmaceutische producten: Andere
Gezondheidstechnologie
Productie

Website: seelostherapeutics.com

Hoofdzetel: New York, New York vlag Verenigde Staten

CEO: Raj Mehra

Werknemers: 20

Aandelen Seelos Therapeutics Inc

Beurswaarde: 4,63 miljoen USD

Effecten: 16,61 miljoen

Beta: 1,64

Mijn selecties